PYLARIFY (F18 Piflufolastat)

Special Notice Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced delivery order to Progenics Pharmaceuticals for the procurement of the following item:

0001:

PYLARIFY® (Piflufolastat F18 Injection), Unit of Issue:

EA, Qty.: 500 The proposed sole source procurement will be made with a price agreement with Progenics Pharmaceuticals on an order placed against VA NAC contract 36F79719D0170. Progenics Pharmaceuticals Inc., a Lantheus company, provided a letter stating they are the sole manufacturer and authorized supplier of PYLARIFY®. This notice is not to be considered a request for quotations or proposals.

No contract will be awarded based on offers received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government.

If no affirmative written response is received within 7 days from the publication of this notice, a contract or order will be issued to Progenics Pharmaceuticals without any further notice. The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements.